Literature DB >> 32490396

Mapping the Trends of Kawasaki Disease in Hawai'i from 1996 to 2018.

Trenton J Dawson1, Cindy T Vuong1, Shani C Y Ma1, Chad R Russell1, Marian E Melish2,3, Andras Bratincsak2,3.   

Abstract

Kawasaki disease is a systemic vasculitis of unknown etiology and is the leading cause of acquired heart disease in children in the developed world. Historically, Hawai'i has had the highest incidence of Kawasaki disease in the United States, likely due to the population's unique ancestral composition. To analyze the epidemiology, demographics and spatiotemporal distribution of Kawasaki disease in Hawai'i, a retrospective chart review was conducted utilizing data from Kapi'olani Medical Center for Women and Children encompassing the period of 1996-2018. A total of 858 patients were analyzed with 877 episodes of Kawasaki disease. On average, 37 episodes of Kawasaki disease were diagnosed annually over the 23-year period. The annual incidence was 32 per 100 000 children <5 years of age. Asian children (66.1%) accounted for the majority of cases, followed by Native Hawaiians and Other Pacific Islanders (16.6%). Unlike Japan and the continental United States, there was no characteristic seasonal pattern in the distribution of Kawasaki disease in Hawai'i, which may be attributed to its tropical climate or the recent changes in global weather patterns. Local geographical differences in the incidence of Kawasaki disease demonstrated that the Windward (Eastern) coast of O'ahu had a higher rate, while the Leeward (Western) coast displayed a lower incidence rate. This could be explained by variations in ethnic composition and weather patterns of certain areas. Future studies could provide geographical weather data and statistical analysis to determine what environmental triggers are correlated with Kawasaki disease trends in the State of Hawai'i. ©Copyright 2020 by University Health Partners of Hawai‘i (UHP Hawai‘i).

Entities:  

Keywords:  Kawasaki disease; aneurysm; coronary artery dilation; epidemiology; incidence

Mesh:

Substances:

Year:  2020        PMID: 32490396      PMCID: PMC7260882     

Source DB:  PubMed          Journal:  Hawaii J Health Soc Welf        ISSN: 2641-5216


  12 in total

1.  Coronary artery dimensions may be misclassified as normal in Kawasaki disease.

Authors:  A de Zorzi; S D Colan; K Gauvreau; A L Baker; R P Sundel; J W Newburger
Journal:  J Pediatr       Date:  1998-08       Impact factor: 4.406

2.  Mucocutaneous lymph node syndrome in the United States.

Authors:  M E Melish; R M Hicks; E J Larson
Journal:  Am J Dis Child       Date:  1976-06

3.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Authors:  T Kawasaki; F Kosaki; S Okawa; I Shigematsu; H Yanagawa
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

Review 4.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

5.  Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016.

Authors:  Nobuko Makino; Yosikazu Nakamura; Mayumi Yashiro; Koki Kosami; Yuri Matsubara; Ryusuke Ae; Yasuko Aoyama; Hiroshi Yanagawa
Journal:  Pediatr Int       Date:  2019-04-16       Impact factor: 1.524

6.  Seasonality and temporal clustering of Kawasaki syndrome.

Authors:  Jane C Burns; Daniel R Cayan; Garrick Tong; Emelia V Bainto; Christena L Turner; Hiroko Shike; Tomisaku Kawasaki; Yosikazu Nakamura; Mayumi Yashiro; Hiroshi Yanagawa
Journal:  Epidemiology       Date:  2005-03       Impact factor: 4.822

Review 7.  Kawasaki syndrome.

Authors:  Jane C Burns; Mary P Glodé
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

8.  Association of Kawasaki disease with tropospheric wind patterns.

Authors:  Xavier Rodó; Joan Ballester; Dan Cayan; Marian E Melish; Yoshikazu Nakamura; Ritei Uehara; Jane C Burns
Journal:  Sci Rep       Date:  2011-11-10       Impact factor: 4.379

9.  Seasonality of Kawasaki disease: a global perspective.

Authors:  Jane C Burns; Lauren Herzog; Olivia Fabri; Adriana H Tremoulet; Xavier Rodó; Ritei Uehara; David Burgner; Emelia Bainto; David Pierce; Mary Tyree; Daniel Cayan
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

10.  Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution.

Authors:  Cedric Manlhiot; Brigitte Mueller; Sunita O'Shea; Haris Majeed; Bailey Bernknopf; Michael Labelle; Katherine V Westcott; Heming Bai; Nita Chahal; Catherine S Birken; Rae S M Yeung; Brian W McCrindle
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

View more
  1 in total

1.  Bridging a diagnostic Kawasaki disease classifier from a microarray platform to a qRT-PCR assay.

Authors:  Rowan Kuiper; Victoria J Wright; Dennie Tempel; Jane C Burns; Michael Levin; Dominic Habgood-Coote; Chisato Shimizu; Daphne Huigh; Adriana H Tremoulet; Danielle van Keulen; Clive J Hoggart; Jesus Rodriguez-Manzano; Jethro A Herberg; Myrsini Kaforou
Journal:  Pediatr Res       Date:  2022-06-22       Impact factor: 3.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.